These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19783884

  • 21. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee JY, Lee SD.
    Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
    [Abstract] [Full Text] [Related]

  • 23. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S, Gane EJ, McCall JL, Plank LD.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M.
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [Abstract] [Full Text] [Related]

  • 25. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

  • 26. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H, Wang H, Sun Y, Guo F, Fang JL, Shao J, Rao HY, Wang J, Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [Abstract] [Full Text] [Related]

  • 27. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [Abstract] [Full Text] [Related]

  • 28. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [Abstract] [Full Text] [Related]

  • 29. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C.
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [Abstract] [Full Text] [Related]

  • 30. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J.
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R.
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [Abstract] [Full Text] [Related]

  • 32. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH, Kim YS, Jang JY, Cheon YG, Kim YS, Cho YD, Lee JS, Lee MS, Kim JH, Shim CS, Kim BS.
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [Abstract] [Full Text] [Related]

  • 33. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 34. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 35. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA.
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [Abstract] [Full Text] [Related]

  • 36. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ, Chen HA, Lu MQ, Chen GH.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2065-9. PubMed ID: 19080277
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ.
    Am J Gastroenterol; 2006 Jul 20; 101(7):1516-23. PubMed ID: 16863555
    [Abstract] [Full Text] [Related]

  • 38. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.
    Clin Ther; 2006 Dec 20; 28(12):2081-92. PubMed ID: 17296464
    [Abstract] [Full Text] [Related]

  • 39. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
    Manousou P, Dhillon AP, Isgro G, Calvaruso V, Luong TV, Tsochatzis E, Xirouchakis E, Kalambokis G, Cross TJ, Rolando N, O'Beirne J, Patch D, Thornburn D, Burroughs AK.
    Liver Transpl; 2011 Feb 20; 17(2):178-88. PubMed ID: 21280191
    [Abstract] [Full Text] [Related]

  • 40. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM.
    Arch Surg; 2005 Jul 20; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.